NARI stock surpasses average analyst target price, trading at $79.45.

From Nasdaq: 2025-01-08 07:06:16

Inari Medical Inc (NARI) shares have surpassed the average analyst target price of $65.38, trading at $79.45. Analysts may adjust target prices based on business developments. There are 13 analyst targets for NARI, with a standard deviation of $10.243. Investors can use the average target price as a signal to assess the company’s valuation. Analyst ratings for NARI show 10 strong buys, 0 buys, and 5 holds, with an average rating of 1.67. Data provided by Zacks Investment Research via Quandl.com.

This article presents the latest information on NARI stock and provides insights into analyst ratings and target prices. Visit the links provided for additional resources and analysis.



Read more at Nasdaq: NARI Crosses Above Average Analyst Target